Stoke Therapeutics
STOK
STOK
88 hedge funds and large institutions have $1.16B invested in Stoke Therapeutics in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+18
Holders Change %
+25.71%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
23
Increased
16
Reduced
28
Closed
5
Calls
$1.48M
Puts
–
Net Calls
+$1.48M
Net Calls Change
+$876K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$39.2M |
| 2 |
Aviva
London,
United Kingdom
|
+$2.23M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$1.58M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.41M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.32M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$26.7M |
| 2 |
Millennium Management
New York
|
-$6.06M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.48M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.66M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.18M |
